Author:
Wu Wen-Ting,Chen Chung-Yu
Abstract
AbstractIn Taiwan, patients with pulmonary hypertension (PH) related to chronic obstructive pulmonary disease (COPD) are most common PH population (group 3). However, efficacy of medical treatments and optimal prevention methods in this group remain uncertain. Statins such as indirect RhoA/Rho-kinase inhibitors influence one of key signalling pathways that promote PH onset. In this study, we explored protective effects of statins against PH in COPD patients using database from Taiwan National Health Insurance programme from 2002 to 2017. The main outcome was the risk of PH. The Cox proportional-hazards model and the Fine and Gray model were used to adjust covariate and competing risks to estimate the subdistribution hazard ratios (sHRs). 553,617 newly diagnosed COPD patients were stratified by statin users (n = 41,168) and statin nonusers (n = 512,449). After 1:1 propensity score matching of statin users (n = 41,163), and 41,163 statin nonusers were included for outcome analysis. Statin users had a 22% lower risk of PH than nonusers (sHR: 0.78, 95% confidence interval: 0.65–0.94). During subgroup analysis, taking higher daily doses and for a longer duration displayed a more significantly reduced risk of PH (both P for trend <0.001). Statins may have a protective effect against PH that is dose- and time-dependent.
Funder
Kaohsiung Medical University
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Hsu, C. H. et al. 2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension. Acta Cardiol. Sin. 30, 401–444 (2014).
2. Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53, https://doi.org/10.1183/13993003.01913-2018 (2019).
3. Badesch, D. B. et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137, 376–387, https://doi.org/10.1378/chest.09-1140 (2010).
4. Peacock, A. J., Murphy, N. F., McMurray, J. J., Caballero, L. & Stewart, S. An epidemiological study of pulmonary arterial hypertension. Eur. Respir. J. 30, 104–109, https://doi.org/10.1183/09031936.00092306 (2007).
5. McGoon, M. D. et al. Pulmonary arterial hypertension: epidemiology and registries. J. Am. Coll. Cardiol. 62, D51–59, https://doi.org/10.1016/j.jacc.2013.10.023 (2013).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献